National Path Lab
Liver & Gastrointestinal Diseases

Fatty Liver Disease / MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously commonly referred to as non-alcoholic fatty liver disease (NAFLD), is associated with metabolic risk factors such as obesity, diabetes, insulin resistance, and abnormal lipid levels.

Laboratory tests help assess liver injury, metabolic risk, and possible alternative causes of liver disease — laboratory results may be combined with clinical assessment and imaging-based fibrosis assessment where appropriate.

At National Path Lab (NPL), comprehensive liver and metabolic testing is available to support the evaluation of suspected fatty liver disease.

Tests available
5
Tests available
Health package
1
Health package

Tests Available at NPL

LIVER FUNCTION TEST PANEL 1

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

GAMMA GLUTAMYL TRANSFERASE; GGT

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 900

COMPLETE BLOOD COUNT

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 500

GLYCOSYLATED HEMOGLOBIN; HBA1C

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

LIPID PROFILE

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

About Fatty Liver Disease / MASLD

Causes & Risk Factors

MASLD is closely tied to metabolic health, with the following recognized risk factors:

•  Obesity, particularly abdominal obesity.

•  Type 2 diabetes and insulin resistance.

•  Metabolic syndrome and its individual components.

•  Abnormal lipid levels, particularly elevated triglycerides.

•  Sedentary lifestyle and diet high in refined sugars and fats.

•  Certain medications and, less commonly, other metabolic or genetic conditions.

Symptoms & When to Test

Fatty liver disease is often asymptomatic, particularly in early stages, and is frequently detected incidentally through imaging or blood tests performed for other reasons.

•  Often asymptomatic, especially in earlier stages

•  Mild fatigue or vague right upper abdominal discomfort in some patients

•  Usually detected incidentally on imaging performed for another reason, or through elevated liver enzymes on routine blood testing

•  In advanced disease (cirrhosis), more specific symptoms of liver dysfunction may develop

When Should You Consider Testing?

Testing may be considered in individuals with fatty liver detected on imaging, obesity or increased waist circumference, diabetes or prediabetes, high triglycerides or cholesterol, elevated liver enzymes, metabolic syndrome, or unexplained abnormal liver function tests.

Why Tests Are Combined

Because fatty liver disease is fundamentally a metabolic condition affecting the liver, testing combines direct liver injury markers (ALT, AST, GGT, ALP, bilirubin) with broader metabolic assessment (HbA1c, lipid profile) to characterize both the liver involvement and its underlying metabolic drivers.

Albumin and platelet count provide information about liver synthetic function and can offer early clues about more advanced disease, since these can become abnormal as fatty liver disease progresses toward fibrosis or cirrhosis.

Viral hepatitis screening is included to exclude viral causes of liver abnormality as an alternative or additional explanation, since a patient can have both fatty liver disease and a separate liver condition simultaneously.

Preparation requirements vary by specific test — please follow the instructions provided by your doctor or NPL for the tests ordered.

Home Sample Collection

NPL offers convenient home sample collection for Fatty Liver Disease / MASLD blood tests, so you don't need to visit a lab in person.

→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.

→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.

→ Your sample is transported under controlled, monitored conditions to NPL's NABL ACCREDITED UNDER ISO 15189:2022 laboratory for processing.

→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.

When to See a Doctor

•  Fatty liver detected on imaging performed for any reason

•  Elevated liver enzymes on routine or incidental blood testing

•  Known obesity, diabetes, or metabolic syndrome with liver-related concerns

•  Unexplained abnormal liver function tests

Medical Disclaimer

Laboratory tests support the evaluation of fatty liver disease but should not be interpreted in isolation. Reference ranges and clinical significance may vary according to the laboratory, patient characteristics, and clinical context. Final interpretation should be made by a qualified healthcare professional.

Related Packages

CELIAC PANEL SCREENING

Test Includes
3 Tests

Rs. 5000

Frequently Asked Questions

ALT, AST, GGT, ALP, bilirubin, albumin, and platelet count may be used along with metabolic tests such as HbA1c and lipid profile. Viral hepatitis screening may also be appropriate to exclude other causes.
In earlier stages, yes — lifestyle changes including weight loss, dietary modification, and increased physical activity can improve or resolve fatty liver disease. Your doctor can advise on an appropriate approach for your situation.
Liver function tests usually do not require fasting, though fasting may be requested when performed as part of a broader metabolic panel that includes fasting glucose or lipids.
Yes, this is possible — liver enzymes can be normal even with significant fatty liver disease present, which is why imaging and, in some cases, further fibrosis assessment can be important alongside blood testing.
MASLD (metabolic dysfunction-associated steatotic liver disease) is the updated terminology that has replaced NAFLD (non-alcoholic fatty liver disease) in current medical usage, reflecting a more precise focus on the metabolic drivers of the condition.